Filing Details
- Accession Number:
- 0001104659-25-012903
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-13 16:01:19
- Reporting Period:
- 2025-02-11
- Filing Date:
- 2025-02-13
- Accepted Time:
- 2025-02-13 16:01:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1295947 | Prestige Consumer Healthcare Inc. | PBH | Pharmaceutical Preparations (2834) | 201297589 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1776953 | Adel Mekhail | 660 White Plains Road Tarrytown NY 10591 | Evp, Marketing & Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-02-11 | 5,400 | $44.33 | 23,765 | No | 4 | M | Direct | |
Common Stock, Par Value $0.01 Per Share | Disposition | 2025-02-11 | 5,400 | $86.82 | 18,365 | No | 4 | S | Direct | |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2025-02-11 | 5,683 | $54.47 | 24,048 | No | 4 | M | Direct | |
Common Stock, Par Value $0.01 Per Share | Disposition | 2025-02-11 | 5,683 | $86.30 | 18,365 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Options (rights to buy) | Disposition | 2025-02-11 | 5,400 | $0.00 | 5,400 | $44.33 |
Common Stock | Employee Stock Options (rights to buy) | Disposition | 2025-02-11 | 5,683 | $0.00 | 5,683 | $54.47 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2031-05-03 | No | 4 | M | Direct | |
2,842 | 2032-05-02 | No | 4 | M | Direct |
Footnotes
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.82.
- Reflects the weighted average sale price. The reporting person effected multiple same-way open market sale transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price. The range of prices for such transaction is $86.00 to $86.30.
- The options vested in three equal installments of 3,655 shares on May 4, 2021, May 4, 2022 and May 4, 2023.
- The options vests in three equal installments of 2,841 shares each on May 2,2023 and 2,842 shares each on May 3, 2024 and May 3, 2025